Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
An 8-year-old child with acute myeloid leukemia (AML), underwent an allogeneic bone marrow transplant (BMT) from his HLA matched sister in spite of having a mild cardiomyopathy. We followed the patient with periodic electrocardiograms (ECG) and echocardiograms which have not worsened, and the patient's quality of life is not compromised 14 years after BMT. Bone Marrow Transplantation (2000) 25, 335-336.
Nicolini
B
B
Department of Pediatric Hematology-Oncology, BMT Unit, University of Milan, San Gerardo Hospital, Monza, Italy.
Balduzzi
A
A
Tagliabue
A
A
Longoni
D
D
Uderzo
C
C
Galli
M A
MA
D000208:Acute Disease; D018943:Anthracyclines / Q000008:administration & dosage; D016026:Bone Marrow Transplantation; D009202:Cardiomyopathies / Q000209:etiology*; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004569:Electroencephalography; D006086:Graft vs Host Disease; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D017567:Karnofsky Performance Status; D007951:Leukemia, Myeloid / Q000150:complications / Q000628:therapy*; D008297:Male; D011788:Quality of Life; D014184:Transplantation, Homologous
D018943:Anthracyclines; D007166:Immunosuppressive Agents; D003561:Cytarabine; D003630:Daunorubicin